Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01749826 · ClinicalTrials.gov registry record · NA
Inflammatory Responses to Acute and Chronic Opioid Exposure in Humans
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01749826: Clinical Trial NA study, sponsored by Stanford University.
NCT01749826 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01749826, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
We aim to examine the extent to which inflammation is affected by acute and chronic opioid exposure.
Interventions
- DRUG Morphine Sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01749826
The ClinicalTrials.gov registry entry for NCT01749826 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Morphine Sulfate is the first listed.
NCT01749826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01749826 about?
NCT01749826 is a clinical study titled "Inflammatory Responses to Acute and Chronic Opioid Exposure in Humans". We aim to examine the extent to which inflammation is affected by acute and chronic opioid exposure.
What is the current status of trial NCT01749826?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2010-01. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01749826?
The interventions under investigation include: Morphine Sulfate (DRUG).
Who is sponsoring clinical trial NCT01749826?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.